PAHC

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ZTS ELAN IDXX NEOG MWG CTLT KMDA MNOV IRWD PTCT

| Held by: IJR IWM VTI SPSM IJT IWO VXF XPH XSMO SCHA

Scroll to Statements

Index	RUT	P/E	23.53	EPS (ttm)	2.26	Insider Own	49.53%	Shs Outstand	20.57M	Perf Week	32.18%
Market Cap	2.15B	Forward P/E	15.77	EPS next Y	3.37	Insider Trans	-1.45%	Shs Float	20.48M	Perf Month	34.59%
Enterprise Value	2.85B	PEG	0.75	EPS next Q	0.71	Inst Own	48.12%	Short Float	5.21%	Perf Quarter	28.97%
Income	92.09M	P/S	1.47	EPS this Y	44.74%	Inst Trans	-5.19%	Short Ratio	3.84	Perf Half Y	94.18%
Sales	1.46B	P/B	6.47	EPS next Y	11.24%	ROA	6.84%	Short Interest	1.07M	Perf YTD	42.05%
Book/sh	8.20	P/C	28.91	EPS next 5Y	21.04%	ROE	31.80%	52W High	50.05 6.03%	Perf Year	137.24%
Cash/sh	1.84	P/FCF	45.55	EPS past 3/5Y	-0.76% 7.45%	ROIC	8.56%	52W Low	16.16 228.40%	Perf 3Y	233.98%
Dividend Est.	0.48 (0.90%)	EV/EBITDA	12.68	Sales past 3/5Y	11.22% 10.12%	Gross Margin	31.78%	Volatility	8.42% 4.79%	Perf 5Y	154.78%
Dividend TTM	0.48 (0.90%)	EV/Sales	1.95	EPS Y/Y TTM	376.49%	Oper. Margin	11.90%	ATR (14)	2.40	Perf 10Y	58.18%
Dividend Ex-Date	Mar 04, 2026	Quick Ratio	1.22	Sales Y/Y TTM	32.39%	Profit Margin	6.29%	RSI (14)	80.73	Recom	2.75
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	3.05	EPS Q/Q	757.29%	SMA20	27.96%	Beta	0.73	Target Price	48.50
Payout	40.46%	Debt/Eq	2.33	Sales Q/Q	20.90%	SMA50	31.47%	Rel Volume	2.33	Prev Close	50.00
Employees	2475	LT Debt/Eq	2.24	Earnings	Feb 04 AMC	SMA200	55.80%	Avg Volume	277.85K	Price	53.07
IPO	Apr 11, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.85% 5.14%	Trades		Volume	646,740	Change	6.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-07-25	Upgrade	JP Morgan	Neutral → Overweight	$35
Jun-16-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$24
Sep-10-24	Initiated	JP Morgan	Neutral	$22
Dec-07-23	Initiated	Exane BNP Paribas	Underperform	$9
Dec-21-22	Initiated	ROTH Capital	Buy	$18
Jul-25-22	Downgrade	Barclays	Equal Weight → Underweight	$22
Jan-10-22	Upgrade	Barclays	Underweight → Equal Weight	$23
Nov-18-21	Initiated	Morgan Stanley	Equal-Weight	$23
Aug-05-21	Resumed	Credit Suisse	Neutral	$25
Jul-07-21	Downgrade	Barclays	Equal Weight → Underweight	$23
Aug-06-20	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$20
Feb-06-20	Downgrade	Gabelli & Co	Buy → Hold	$30
Jan-28-20	Upgrade	Barclays	Underweight → Equal Weight
Sep-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$21 → $30
Aug-29-19	Reiterated	BofA/Merrill	Underperform	$29 → $18
Jun-11-19	Initiated	Barclays	Underweight	$25
May-23-19	Initiated	Guggenheim	Neutral
May-09-19	Upgrade	Gabelli & Co	Hold → Buy	$42
Aug-23-17	Resumed	BofA/Merrill	Underperform	$33
Jun-02-17	Downgrade	Credit Suisse	Outperform → Neutral

Show Previous Ratings

Feb-06-26 01:22PM	Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates (Zacks) +6.14%
12:45PM	3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks)
10:48AM	MCK Q3 Earnings & Sales Top Estimates, 2026 View Up (Zacks)
09:50AM	Phibro Animal Health (PAHC) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:15AM	Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:07AM	Loading…
08:07AM	QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down (Zacks)
08:03AM	RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Feb-05-26 11:37PM	Phibro Animal Health Q2 Earnings Call Highlights (MarketBeat) +21.95%
04:01PM	Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
03:32PM	Stock Market Today: Dow, Nasdaq Struggle; Animal Health Name Soars (Live Coverage) (Investor's Business Daily)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
Feb-04-26 07:30PM	Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics (Zacks)
06:15PM	Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
05:39PM	Phibro Animal Health (NASDAQ:PAHC) Misses Q2 CY2026 Revenue Estimates, But Stock Soars 5.5% (StockStory)
05:13PM	Phibro: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:25PM	Loading…
04:25PM	Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance (Business Wire)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
Feb-03-26 04:10PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
Feb-02-26 09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
Jan-30-26 10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
09:45AM	Phibro Animal Health (PAHC) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Jan-29-26 08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Jan-28-26 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results (Business Wire)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:46AM	PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results (Zacks)
Jan-26-26 11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Loading…
09:40AM	Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? (Zacks)
Jan-23-26 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks) -6.25%
Jan-22-26 08:40AM	Abbott (ABT) Matches Q4 Earnings Estimates (Zacks)
Jan-21-26 08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 08:36AM	Should You Still Hold GMED Stock in Your Portfolio? (Zacks)
Jan-16-26 09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks)
09:42AM	Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? (Zacks)
09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
12:00PM	Phibro (PAHC) Upgraded to Strong Buy: Here's Why (Zacks)
11:05AM	KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery (Zacks)
09:45AM	Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock (Zacks)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
07:19AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? (Zacks)
Jan-09-26 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) (Zacks)
11:40AM	PAHC vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 09:40AM	Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? (Zacks)
09:31AM	Zacks.com featured highlights include Animal Health, Commercial Metals, Fox and Adtalem Global Education (Zacks)
08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 03:00PM	4 PEG-Based GARP Picks for Navigating Early-2026 Market Uncertainty (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
07:25AM	IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? (Zacks)
Jan-06-26 08:12AM	Should Labcorp Stock Stay in Your Portfolio Right Now? (Zacks)
Jan-02-26 06:17PM	Phibro Animal Health (NASDAQ:PAHC) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings (StockStory)
07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
03:46AM	Best Growth Stocks to Buy for January 2nd (Zacks)
Dec-30-25 07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
05:08AM	Best Growth Stocks to Buy for December 30th (Zacks)
Dec-29-25 10:57AM	Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA (Zacks)
08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Dec-24-25 12:45PM	Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
04:25AM	Best Growth Stocks to Buy for Dec. 24 (Zacks)
Dec-22-25 09:45AM	Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term (Zacks)
03:27AM	Best Growth Stocks to Buy for Dec. 22 (Zacks)
Dec-19-25 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks) -7.82%
Dec-18-25 04:10PM	Phibro Animal Health Corporation Announces Leadership Transition (Business Wire)
05:26AM	Best Growth Stocks to Buy for Dec. 18 (Zacks)
Dec-16-25 07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
05:35AM	Best Growth Stocks to Buy for Dec. 16 (Zacks)
05:21AM	Best Value Stocks to Buy for Dec. 16 (Zacks)
Dec-15-25 09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-10-25 08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:23AM	Best Growth Stocks to Buy for December 9th (Zacks)
Dec-08-25 12:45PM	Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
Dec-05-25 11:30AM	Why Is Phibro (PAHC) Down 5.3% Since Last Earnings Report? (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-04-25 05:02AM	Zacks.com featured highlights include Phibro Animal Health, Argan and Ubiquiti (Zacks)
Dec-03-25 09:55AM	Here's Why Phibro (PAHC) Could be Great Choice for a Bottom Fisher (Zacks)
09:45AM	Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock (Zacks)
09:26AM	3 Momentum Anomaly Stocks to Buy as Markets Gear Up for 2025 Swansong (Zacks)
Nov-27-25 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Nov-25-25 12:42PM	Agilent Q4 Earnings Match Estimates, Revenues Up Y/Y, Shares Fall (Zacks)
09:50AM	Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-21-25 04:27AM	Zacks.com featured highlights include Phibro Animal Health, Astronics, CommScope and Heritage Insurance (Zacks)
Nov-20-25 03:00PM	Four PEG-Driven GARP Winners for the Uncertainty of November 2025 (Zacks)
12:00PM	Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
10:45AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BENDHEIM JACK	President and CEO	Feb 03 '26	Sale	41.47	9,660	400,610	22,320	Feb 05 07:22 PM
BENDHEIM JACK	President and CEO	Feb 04 '26	Sale	41.15	3,520	144,863	48,800	Feb 05 07:22 PM
BENDHEIM JACK	President and CEO	Jan 29 '26	Sale	40.12	6,772	271,687	38,673	Feb 02 04:15 PM
BENDHEIM JACK	President and CEO	Jan 30 '26	Sale	40.09	6,693	268,350	31,980	Feb 02 04:15 PM
BENDHEIM JACK	President and CEO	Jan 23 '26	Sale	40.55	1,235	50,084	15,445	Jan 27 04:15 PM
BENDHEIM JACK	President and CEO	Jan 21 '26	Sale	41.68	14,687	612,128	29,838	Jan 22 07:41 PM
BENDHEIM JACK	President and CEO	Jan 22 '26	Sale	41.98	13,158	552,420	18	Jan 22 07:41 PM
BENDHEIM JACK	President and CEO	Jan 13 '26	Sale	40.32	7,551	304,422	31,108	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 14 '26	Sale	40.53	3,651	147,983	47,457	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 15 '26	Sale	40.02	2,932	117,348	44,525	Jan 15 06:24 PM
BENDHEIM JACK	President and CEO	Jan 09 '26	Sale	40.16	213	8,554	38,659	Jan 13 06:53 PM
BENDHEIM JACK	President and CEO	Jan 07 '26	Sale	40.09	328	13,149	38,872	Jan 08 06:07 PM
BENDHEIM JACK	President and CEO	Dec 11 '25	Sale	40.93	5,752	235,405	39,200	Dec 15 04:51 PM
BENDHEIM JACK	President and CEO	Dec 08 '25	Sale	40.06	3,520	141,018	46,240	Dec 10 04:15 PM
BENDHEIM JACK	President and CEO	Dec 09 '25	Sale	40.19	1,288	51,763	44,952	Dec 10 04:15 PM
BENDHEIM JACK	President and CEO	Dec 04 '25	Sale	41.22	3,520	145,096	49,760	Dec 04 06:34 PM
BENDHEIM JACK	President and CEO	Dec 03 '25	Sale	40.77	3,520	143,511	53,280	Dec 04 06:34 PM
BFI Co. LLC	10% Owner	Dec 04 '25	Proposed Sale	40.77	316,800	12,915,936		Dec 04 05:07 PM
BENDHEIM JACK	President and CEO	Nov 28 '25	Sale	42.54	3,520	149,740	30,320	Dec 02 04:15 PM
BENDHEIM JACK	President and CEO	Dec 01 '25	Sale	41.66	3,520	146,636	26,800	Dec 02 04:15 PM
BENDHEIM JACK	President and CEO	Nov 25 '25	Sale	43.93	7,040	309,240	39,120	Nov 26 05:46 PM
BENDHEIM JACK	President and CEO	Nov 26 '25	Sale	44.02	5,280	232,434	33,840	Nov 26 05:46 PM
BENDHEIM JACK	President and CEO	Nov 20 '25	Sale	41.76	3,520	147,002	46,160	Nov 24 04:15 PM
BENDHEIM JACK	President and CEO	Nov 17 '25	Sale	44.56	5,280	235,254	54,960	Nov 18 07:50 PM
BENDHEIM JACK	President and CEO	Nov 18 '25	Sale	43.82	5,280	231,377	49,680	Nov 18 07:50 PM
BENDHEIM JACK	President and CEO	Nov 12 '25	Sale	45.23	21,536	973,976	14,041	Nov 13 08:24 PM
BENDHEIM JACK	President and CEO	Nov 13 '25	Sale	44.47	8,801	391,417	5,240	Nov 13 08:24 PM
BENDHEIM JACK	President and CEO	Nov 10 '25	Sale	45.29	38,303	1,734,767	20,577	Nov 10 07:50 PM
BENDHEIM JACK	President and CEO	Nov 07 '25	Sale	42.86	3,520	150,851	58,880	Nov 10 07:50 PM
BENDHEIM JACK	President and CEO	Nov 04 '25	Sale	43.10	3,520	151,703	65,920	Nov 06 05:46 PM
BENDHEIM JACK	President and CEO	Nov 05 '25	Sale	41.21	3,520	145,075	62,400	Nov 06 05:46 PM
BENDHEIM JACK	President and CEO	Oct 29 '25	Sale	41.66	3,520	146,627	47,960	Oct 30 06:09 PM
BENDHEIM JACK	President and CEO	Oct 28 '25	Sale	41.56	3,520	146,277	51,480	Oct 30 06:09 PM
BENDHEIM JACK	President and CEO	Oct 30 '25	Sale	41.07	3,520	144,582	44,440	Oct 30 06:09 PM
BENDHEIM JACK	President and CEO	Oct 22 '25	Sale	40.27	11,859	477,552	62,040	Oct 24 07:06 PM
BENDHEIM JACK	President and CEO	Oct 24 '25	Sale	41.75	3,520	146,956	55,000	Oct 24 07:06 PM
BENDHEIM JACK	President and CEO	Oct 23 '25	Sale	40.18	3,520	141,432	58,520	Oct 24 07:06 PM
BENDHEIM JACK	President and CEO	Oct 20 '25	Sale	40.38	16,075	649,176	23,899	Oct 21 05:30 PM
BENDHEIM JACK	President and CEO	Oct 17 '25	Sale	40.03	700	28,022	39,974	Oct 21 05:30 PM
BENDHEIM JACK	President and CEO	Sep 30 '25	Sale	40.38	20,664	834,412	40,674	Oct 01 04:10 PM
BENDHEIM JACK	President and CEO	Sep 18 '25	Sale	40.26	7,022	282,732	31,338	Sep 22 06:32 PM
BENDHEIM JACK	President and CEO	Sep 09 '25	Sale	40.33	14,080	567,841	45,400	Sep 11 08:56 PM
BENDHEIM JACK	President and CEO	Sep 10 '25	Sale	41.29	3,520	145,336	41,880	Sep 11 08:56 PM
BENDHEIM JACK	President and CEO	Sep 11 '25	Sale	40.95	3,520	144,137	38,360	Sep 11 08:56 PM
BFI Co. LLC	10% Owner	Sep 04 '25	Proposed Sale	39.07	281,600	11,002,112		Sep 04 05:04 PM
BFI Co., LLC	10% Owner	Aug 19 '25	Proposed Sale	31.25	264,000	8,250,000		Aug 19 04:40 PM
BFI Co., LLC	10% Owner	May 19 '25	Proposed Sale	24.00	241,129	5,787,096		May 19 05:25 PM
CORCORAN E THOMAS	Director	Feb 24 '25	Buy	22.10	5,000	110,500	30,000	Feb 26 04:15 PM
BFI Co., LLC	10% Owner	Feb 18 '25	Proposed Sale	25.77	247,769	6,385,007		Feb 18 05:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Phibro Animal Health Corp

Upgrade your FINVIZ experience